BNET Industries
Cephalon Inc. is in the Health Care Industry
Latest News and Analysis
SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial
ChinaBio Today submits: Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility. Adefovir dipivoxil, the drug newly approved for marketing, is aimed at hepatitis B. It is currently...
Cephalon, Inc. Q2 2008 Earnings Call
Cephalon, Inc. CEPH Q2 FY08 Earnings Call
Cephalon Announces Issuance of Patent for AMRIX
FRAZER, Pa., June 17 /PRNewswire-FirstCall/ -- Cephalon, Inc. announced today that the U.S. Patent and Trademark Office has issued a pharmaceutical formulation patent for AMRIXR (Cyclobenzaprine Hydrochloride Extended-Release Capsules). U.S. Patent No. 7,387,793 was issued to Eurand Inc., the developer of AMRIX, and expires on February 26,...
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
FRAZER, Pa., June 3 /PRNewswire-FirstCall/ -- Cephalon, Inc. today announced that it and its wholly-owned subsidiary CIMA LABS INC. have filed a lawsuit in U.S. District Court in Delaware against Watson Pharmaceuticals, Inc. and its wholly-owned subsidiary, Watson Laboratories, Inc., for infringement of U.S. Patent Nos. 6,200,604 and...
Zacks Analyst Blog Highlights: Eurand NV, Cephalon, GlaxoSmithKline, Kodiak Oil & Gas and Devon Energy
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eurand NV (Nasdaq: EURX), Cephalon (Nasdaq: CEPH), GlaxoSmithKline (NYSE: GSK), Kodiak...
Cephalon, Inc. Q1 2008 Earnings Call Transcript
Cephalon, Inc. Q1 2008 Earnings Call Transcript
The Franklin Institute Receives Record $4 Million Gift from Biopharmaceutical Leader, Cephalon
Gift to Support Creation of Brain Exhibit
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
First New Agent for CLL Patients Approved by the FDA Since 2001
Zacks Analyst Blog Highlights: Eurand NV, Cephalon and GlaxoSmithKline
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eurand NV (Nasdaq: EURX), Cephalon, Inc. (Nasdaq: CEPH) and GlaxoSmithKline (NYSE:...
Cephalon, Inc. Q4 2007 Earnings Call Transcript
Cephalon, Inc. Q4 2007 Earnings Call Transcript
Zacks Analyst Blog Highlights: U.S. Cellular, Telephone and Data Systems, Eurand NV and Cephalon
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: U.S. Cellular (NYSE: USM), Telephone and Data Systems (NYSE: TDI), Eurand...
Zacks Analyst Blog Highlights: Alkermes, Johnson & Johnson, Cephalon and SanDisk
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alkermes, Inc. (Nasdaq: ALKS), Johnson & Johnson (NYSE: JNJ), Cephalon (Nasdaq:...
Research and Markets: Cephalon Inc. Company Analysis Is Available Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76710) has announced the addition of " - Cephalon Inc." to their offering.
Cephalon Q3 2007 Earnings Call Transcript
Cephalon Q3 2007 Earnings Call Transcript
PsychoGenics Announces Drug Discovery Agreement with Cephalon
Companies Will Work Together to Identify New Treatments for Neuropsychiatric Disorders
Research and Markets: Cephalon IMS Company Profile Available Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c71557) has announced the addition of "Cephalon IMS Company Profile" to their offering.
Research and Markets: New Report Profiles Dealmaking Activity at Cephalon
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c67630) has announced the addition of Cephalon Dealmaking Profile 2007 to their offering.
Instem Partners with Cephalon to Optimize Pre-Clinical Data Collection and Processing
Provantis Preclinical Solution Chosen from Competitive Evaluation to Replace In-House Systems and Manual Processes
Cephalon, Inc. to Acquire Amrix(R) - a Eurand Diffucaps(R) Product.
MILAN, Italy and DAYTON, Ohio, August 23 /PRNewswire/ -- MILAN, Italy and DAYTON, Ohio, August 23 /PRNewswire/ --
All Star Analysts Portfolio highlights: AMETEK, Cephalon, Helix Energy Solutions and Marriott Int'l
CHICAGO -- Zacks.com just released its latest additions and deletions to its proprietary All Star Analyst portfolio. Members on this exclusive list include AMETEK, Inc. (NYSE: AME), Cephalon, Inc. (NASDAQ: CEPH), Helix Energy Solutions (NYSE: HLX) and Marriott International, Inc. (NYSE: MAR). View the entire list of stocks on the...
- Next »
- page 1 of 6
- « Previous
Sort byClose
View by Content TypeClose
Cephalon Inc. Company Info
NAICS Code
Medical Laboratories: 621511
